Shopping Cart
- Remove All
Your shopping cart is currently empty
Eriosemation significant androgen receptor (AR) inhibition activity, suggests that it could be a promising candidate for further evaluation for prostate cancer prevention or management.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $620 | Backorder |
| Description | Eriosemation significant androgen receptor (AR) inhibition activity, suggests that it could be a promising candidate for further evaluation for prostate cancer prevention or management. |
| Synonyms | 5,7-Dihydroxy-6,8-diprenylchromone |
| Molecular Weight | 314.38 |
| Formula | C19H22O4 |
| Cas No. | 162616-72-0 |
| Relative Density. | 1.184 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.